ACCESS-AD

ACCESS-AD: a new European initiative to accelerate timely and equitable AD diagnosis, treatment and care Developed by a consortium of 30 public and private partners, ACCESS-AD (“Advancing Clinical Care and Equity through Scalable Solutions in Alzheimer’s Disease diagnosis and treatment”...

Missed the ACCESS-AD launch and want to learn more?
Visit our website ▶️ www.access-ad.org
Check out our press release 📖https://www.eurekalert.org/news-releases/1112308
....And follow along for updates as our work moves forward!

16.01.2026 17:41 — 👍 0    🔁 0    💬 0    📌 0

Earlier this week, we launched ACCESS-AD 🚀

Today, we’re sharing a short video on how our @ihieurope.bsky.social project aims to support earlier diagnosis, safer treatment and better monitoring for #Alzheimer’s disease.

🎬 Watch the video to learn more and stay tuned!

16.01.2026 17:41 — 👍 1    🔁 2    💬 1    📌 0

👋 Say hello to new project @access-ad.bsky.social! They want to innovate how #AlzheimersDisease is diagnosed and treated in routine clinical practice - strengthening the care pathway with a vision of personalised care for every patient. #EUResearch #IHITransformingHealth #HealthInnovation

14.01.2026 08:13 — 👍 3    🔁 2    💬 0    📌 0

📣Follow @access-ad.bsky.social, a new @ihieurope.bsky.social project, ensuring that advances in early detection, biomarker innovation and data infrastructure translate into improved diagnosis, treatment and care.

👉 Visit the project's website for more information: access-ad.org

13.01.2026 12:19 — 👍 4    🔁 2    💬 0    📌 0

ACCESS-AD: a new European initiative to accelerate timely and equitable AD diagnosis, treatment and care Developed by a consortium of 30 public and private partners, ACCESS-AD (“Advancing Clinical Care and Equity through Scalable Solutions in Alzheimer’s Disease diagnosis and treatment”...

Today is the launch of @access-ad.bsky.social, a five-year @ihieurope.bsky.social project advancing timely diagnosis and equitable treatment for Alzheimer’s disease across Europe.

We are delighted to be a partner in supporting this initiative together.

Learn more here: bit.ly/ACCESS-AD_la...

13.01.2026 13:43 — 👍 6    🔁 2    💬 0    📌 0

@access-ad.bsky.social builds on other @ihieurope.bsky.social initiatives including @ihi-prominent.bsky.social, @predictom.bsky.social, AD-RIDDLE and EPND, ensuring that advances in early detection, biomarker innovation and data infrastructure translate into improved diagnosis, treatment and care.

13.01.2026 10:09 — 👍 2    🔁 1    💬 0    📌 0

access-ad – Ensuring timely diagnosis and equitable treatment for Alzheimer’s disease across Europe

Want to learn more about our vision, mission and consortium of public and private partners?

▶️ Visit our website: www.access-ad.org

13.01.2026 09:06 — 👍 3    🔁 1    💬 0    📌 0

A graphic with details about the ACCESS-AD project, detailing the number of partner organisations (30), countries involved (13) and project duration (5 years). A link to the website and contact email is also provided, and all funding organisations are acknowledged in the lower half of the graphic. The graphic features the ACCESS-AD logo, which depicts a brain composed of small, round dots in orange, and shades of teal. The tagline for the project is "Advancing Alzheimer's Disease Care".

👋Hello from ACCESS-AD!

We’re delighted to launch ACCESS-AD, a new @ihieurope.bsky.social project focused on bringing #Alzheimer’s disease innovation into routine clinical practice - supporting timely diagnosis, treatment & monitoring across Europe 🇪🇺

Read our press release: bit.ly/ACCESS-AD_la...

13.01.2026 09:06 — 👍 13    🔁 7    💬 1    📌 3